Elżbieta U. Stolarczyk obtained
her M.Sc. in chemistry from Faculty of Chemistry at University of Warsaw,
Poland. In 2009 defended doctoral thesis at Medical University of Warsaw,
Faculty of Pharmacy (Ph.D.). In September 2022 received a postdoctoral degree
in Pharmaceutical Science (habilitation) at Faculty of Pharmacy, Medical
University of Warsaw, Poland. Ph.D.D.Sc. Elżbieta Stolarczyk has over 20 years
of professional experience in the field of research and development. Research
expertise: active pharmaceutical ingredients (APIs), raw materials, drug
products (FDP), excipients, nanomaterials; experimental techniques: gas
chromatography (GC), liquid chromatography (HPLC), mass spectrometry (MS,
GC-MS, LC-MS/MS), UV–Vis spectroscopy, IR spectroscopy; research
activities/research interests - technologies, documentation, development of
novel analytical methodologies, nanosynthesis, nanotechnology. She has extensive
knowledge in the development of new analytical methods for assay and purity
determination of starting materials, intermediates, residual solvents, impurity
profiling, stress degradation studies, validation. Currently, she is an expert
in analytics and control of pharmaceutical substances and finished drug product
at National Medicines Institute. She is Head of Spectrometric Methods
Department.
Elżbieta U. Stolarczyk obtained
her M.Sc. in chemistry from Faculty of Chemistry at University of Warsaw,
Poland. In 2009 defended doctoral thesis at Medical University of Warsaw,
Faculty of Pharmacy (Ph.D.). In September 2022 received a postdoctoral degree
in Pharmaceutical Science (habilitation) at Faculty of Pharmacy, Medical
University of Warsaw, Poland. Ph.D.D.Sc. Elżbieta Stolarczyk has over 20 years
of professional experience in the field of research and development. Research
expertise: active pharmaceutical ingredients (APIs), raw materials, drug
products (FDP), excipients, nanomaterials; experimental techniques: gas
chromatography (GC), liquid chromatography (HPLC), mass spectrometry (MS,
GC-MS, LC-MS/MS), UV–Vis spectroscopy, IR spectroscopy; research
activities/research interests - technologies, documentation, development of
novel analytical methodologies, nanosynthesis, nanotechnology. She has extensive
knowledge in the development of new analytical methods for assay and purity
determination of starting materials, intermediates, residual solvents, impurity
profiling, stress degradation studies, validation. Currently, she is an expert
in analytics and control of pharmaceutical substances and finished drug product
at National Medicines Institute. She is Head of Spectrometric Methods
Department.